SleepFix for Youth: Digital Behavioural Therapy for Insomnia With E-Psychologist Support
iSLEEPY
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
This pilot randomised, open-label, parallel-group controlled trial will evaluate the feasibility, acceptability and effects of a psychologist-supported digital behavioural therapy for insomnia (dBTi) compared to a wait-listed active control (digital sleep health education) in young people aged 16-24 years with insomnia symptoms. The primary objectives are to evaluate the feasibility of conducting a full-scale trial by assessing recruitment, consent and randomisation rates, intervention uptake, and data completeness. Secondary objectives include exploring treatment effects on insomnia severity (Insomnia Severity Index), sleep diary metrics, sleep quality, fatigue, and mood (depression and anxiety symptoms). Post-intervention interviews will assess participant experience and acceptability. Results will inform the design of a larger randomised controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 12, 2026
August 1, 2025
9 months
November 24, 2025
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
1. Feasibility measure: Trial efficiency data
To evaluate feasibility based on trial efficiency. Data will be assessed by: 1. the proportion of participants who are issued an online pre-screening number and then meet criteria for telephone screening; 2. the proportion of participants who are issued a telephone screening number indicating eligibility and then provide consent; 3. the proportion of participants who provide consent and then are randomised into the trial.
Baseline (Week 0)
2. Feasibility measure: Intervention uptake
To evaluate feasibility based on Intervention uptake. Data will be assessed by: a. the proportion of participants randomised to SleepFix intervention group who download the SleepFix app and then enter personalised data to obtain a prescribed sleep restriction window.
6 weeks
Feasibility measure: Data Completion of Insomnia Severity Index
The Insomnia Severity Index (ISI) is a 7-item questionnaire used to examine overall insomnia severity. It consists of a five-point Likert type scale for each item (ranging from "no problem" = 0 to "severe problem" = 4) regarding symptoms over the past 2 weeks. All items are summed with total scores ranging from 0-28. Higher scores indicate more severe insomnia. The investigators will count the proportion of participants randomised that successfully complete the ISI at Week 6 and Week 14 (this is two outcomes).
Week 6 and Week 14
Secondary Outcomes (15)
Effects of the SleepFix intervention on ISI scores
Week 6 and Week 14
Assessing data completeness: 7-day sleep diaries
Week 6 and week 14
Assessing data completeness: Brief Pittsburgh Sleep Quality Index (B-PSQI)
Week 6 and Week 14
Assessing data completeness: The Flinders Fatigue Scale (FFS)
Week 6 and Week 14
Assessing data completeness: Patient Health Questionnaire-2 (PHQ-2)
Week 6 and Week 14
- +10 more secondary outcomes
Other Outcomes (1)
Number e-psychologist support calls accessed
Week 6
Study Arms (2)
Treatment: SleepFix + e-psychologist support calls
EXPERIMENTALParticipants receive the SleepFix mobile application with weekly support calls from an e-psychologist for 3 weeks, with an optional additional 3 weeks of use. SleepFix will deliver digital brief behavioural therapy for insomnia (dBBTi) based on sleep consolidation therapy. The program aims to improve sleep efficiency by tailoring a personalised sleep window and gradually adjusting it. Participants will be instructed to use SleepFix for a 3-week period, with the option to continue for up to an additional 3 weeks. Weekly 15-20 minute sleep support calls from a trained e-psychologist will provide guidance, troubleshooting, and encouragement throughout the intervention period. Participants will also receive access to educational videos on sleep retraining.
Sleep Health Education (Active Control)
ACTIVE COMPARATORParticipants randomised to this arm will receive three online sleep health education modules delivered via email every two weeks over a 6-week period. The modules provide information on sleep and healthy sleep habits. Control group participants will be offered full access to the SleepFix application with the weekly support calls from an e-psychologist after completing their final follow-up assessment at week 14.
Interventions
SleepFix mobile application uses Sleep Retraining Therapy (SRT) which aims to reduce excess time spent in bed awake and reset sleep by matching time in bed to total sleep time (TST). There are four stages to the SleepFix app and participants will progress based on completion of each stage. Participants are required to enter sleep and bedtime/wake data into the smartphone app for baseline referencing and determination of sleep therapy. SleepFix uses an algorithm that calculates optimal sleep efficiency based on participants data
Three online sleep health education modules are provided to participants. It included information about healthy sleep, insomnia, sleep hygiene practices and information on general strategies for managing sleep for insomnia.
Eligibility Criteria
You may qualify if:
- years old
- Able to give informed online consent and if younger \<18years old guardian/parental consent
- Insomnia Severity Index ≥ 10
- English fluency
- Access to a smartphone and willingness to use a mobile app for healthcare
You may not qualify if:
- Shift-workers with regular shifts between the hours of 8pm and 8am.
- Recent travel to a destination with \>2 hours time difference (within last 7-days and with subjective reports that they are not experiencing jet lag).
- Serious medical and/or psychiatric illnesses/disorders (e.g., Epilepsy or other seizure disorders, heart failure, bipolar disorder, schizophrenia, Major Depressive disorder)
- Self-reported/diagnosed sleep disorders other than insomnia (e.g. - Obstructive Sleep Apnoea, REM/NREM sleep disorders, Restless Leg Syndrome, Narcolepsy, free running cycle \& Circadian rhythm disorder)
- Currently receiving or previously received (within the last 12 months) psychotherapy for insomnia including Cognitive Behavioural Therapy (CBT).
- Pregnant
- Professional driver or operate heavy machinery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Aji M, Glozier N, Bartlett DJ, Grunstein RR, Calvo RA, Marshall NS, White DP, Gordon C. The Effectiveness of Digital Insomnia Treatment with Adjunctive Wearable Technology: A Pilot Randomized Controlled Trial. Behav Sleep Med. 2022 Sep-Oct;20(5):570-583. doi: 10.1080/15402002.2021.1967157. Epub 2021 Aug 20.
PMID: 34415819BACKGROUNDGordon CJ, Cheung JMY, Schrire ZM, Rahimi M, Aji M, Salomon H, Doggett I, Glozier N, Wong KKH, Marshall NS, Bartlett DJ, Grunstein RR. Integrating digital behavioural therapy for insomnia into primary care: A feasibility mixed-methods study. J Sleep Res. 2025 Jun;34(3):e14401. doi: 10.1111/jsr.14401. Epub 2024 Nov 12.
PMID: 39533507BACKGROUNDMorin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601.
PMID: 21532953BACKGROUNDGradisar M, Lack L, Richards H, Harris J, Gallasch J, Boundy M, Johnston A. The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia. J Clin Sleep Med. 2007 Dec 15;3(7):722-8.
PMID: 18198807BACKGROUNDLowe B, Kroenke K, Grafe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005 Feb;58(2):163-71. doi: 10.1016/j.jpsychores.2004.09.006.
PMID: 15820844BACKGROUNDKroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. doi: 10.7326/0003-4819-146-5-200703060-00004.
PMID: 17339617BACKGROUNDSancho-Domingo C, Carballo JL, Coloma-Carmona A, Buysse DJ. Brief version of the Pittsburgh Sleep Quality Index (B-PSQI) and measurement invariance across gender and age in a population-based sample. Psychol Assess. 2021 Feb;33(2):111-121. doi: 10.1037/pas0000959. Epub 2020 Oct 29.
PMID: 33119375BACKGROUNDGalgut Y, Hoyos C, Kempler L, Aji M, Grunstein RR, Gordon CJ, Bartlett DJ. Cognitive and behavioural therapy for insomnia in the treatment of adolescent insomnia: A systematic review and meta-analysis of randomised controlled trials. J Sleep Res. 2025 Aug;34(4):e14442. doi: 10.1111/jsr.14442. Epub 2024 Dec 16.
PMID: 39680961BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Professor Delwyn Bartlett
Woolcock Institute of Medical Research
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The research staff, e-psychologist and Principle Chief Investigator will not be blinded to the study as they will be managing the online study directly which will lend itself to knowing which groups participants are allocated to. Participants will not be blinded as they will know what treatment they receive.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2025
First Posted
February 12, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 12, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
The trial investigators will be given access to the cleaned data set. The project data set will be housed online in the study web portal created for the study, and all data will be password protected. To ensure confidentiality, data dispersed to project team members will be blinded of any identifying participant information. Data will not be shared without permission of Principal Investigators. All data available for sharing will be stored on a web-based database located in Australia. After the study, a non-identified dataset may be made available online in a data repository.